MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 225 filers reported holding MYRIAD GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $875,000 | -36.8% | 30,097 | 0.0% | 0.99% | -26.3% |
| Q3 2018 | $1,384,000 | +23.0% | 30,097 | 0.0% | 1.35% | +23.6% |
| Q2 2018 | $1,125,000 | +26.5% | 30,097 | 0.0% | 1.09% | +23.8% |
| Q1 2018 | $889,000 | -82.0% | 30,097 | -79.1% | 0.88% | -81.9% |
| Q4 2017 | $4,949,000 | -0.2% | 144,097 | +5.1% | 4.88% | -13.9% |
| Q3 2017 | $4,961,000 | +22.2% | 137,111 | -12.7% | 5.67% | +21.3% |
| Q2 2017 | $4,060,000 | +34.6% | 157,111 | 0.0% | 4.67% | +41.2% |
| Q1 2017 | $3,017,000 | +33.1% | 157,111 | +15.6% | 3.31% | +31.5% |
| Q4 2016 | $2,266,000 | +15.3% | 135,911 | +42.3% | 2.52% | +19.0% |
| Q3 2016 | $1,966,000 | -25.7% | 95,511 | +22.7% | 2.11% | -16.9% |
| Q2 2015 | $2,645,000 | -4.0% | 77,810 | 0.0% | 2.54% | +3.3% |
| Q1 2015 | $2,754,000 | +3.9% | 77,810 | 0.0% | 2.46% | -5.4% |
| Q4 2014 | $2,650,000 | – | 77,810 | – | 2.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,000,000 | $45,360,000 | 2.60% |
| Tieton Capital Management, LLC | 166,441 | $1,887,000 | 2.36% |
| S&T BANK/PA | 315,835 | $3,582,000 | 0.82% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,194,204 | $24,882,000 | 0.60% |
| XTX MARKETS LLC | 14,807 | $168,000 | 0.57% |
| Glenview Capital Management | 1,810,727 | $20,534,000 | 0.57% |
| EARNEST PARTNERS LLC | 4,761,082 | $53,991,000 | 0.51% |
| AIMZ Investment Advisors, LLC | 42,685 | $484,000 | 0.31% |
| DUALITY ADVISERS, LP | 163,717 | $1,857,000 | 0.17% |
| Engineers Gate Manager LP | 219,922 | $2,494,000 | 0.13% |